Home > Boards > US Listed > Cannabis > Zynerba Pharmaceuticals (ZYNE)

WOW...LOL...Glad its not just me.You still in ?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dhbuzz Member Profile
 
Followed By 9
Posts 2,776
Boards Moderated 0
Alias Born 03/01/19
160x600 placeholder
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/11/2021 4:06:24 PM
Zynerba Pharmaceuticals Presents Sleep Data from Study of Zygel™ in Children and Adolescents with Both Developmental and Ep... GlobeNewswire Inc. - 6/11/2021 12:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/9/2021 4:11:27 PM
Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting GlobeNewswire Inc. - 6/9/2021 4:05:00 PM
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Securities of... GlobeNewswire Inc. - 6/7/2021 8:00:00 AM
Zynerba Pharmaceuticals Announces Acceptance of Poster at the Associated Professional Sleep Societies SLEEP 2021 Annual Meeti... GlobeNewswire Inc. - 6/4/2021 7:30:00 AM
Zynerba Pharmaceuticals Announces Presentation of Efficacy and Safety Findings in Children and Adolescents with Autism Spectr... GlobeNewswire Inc. - 6/3/2021 10:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/2/2021 9:00:50 AM
Zynerba Pharmaceuticals stock downgraded from Strong Buy Candidate to Buy Candidate after Thursday trading session. StockInvest.us - 5/27/2021 8:09:49 PM
Zynerba Pharmaceuticals Announces Acceptance of Poster at the 2021 American Society of Clinical Psychopharmacology (ASCP) Ann... GlobeNewswire Inc. - 5/27/2021 7:30:00 AM
Zynerba Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire Inc. - 5/26/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/26/2021 7:01:49 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/12/2021 9:23:45 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/12/2021 7:31:34 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/12/2021 7:01:39 AM
Zynerba Pharmaceuticals EPS beats by $0.05 Seeking Alpha - 5/12/2021 6:55:46 AM
Zynerba Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Highlights GlobeNewswire Inc. - 5/12/2021 6:45:00 AM
Zynerba Pharma Receives FDA Guidance For Phase 3 Trial Of Zygel; Street Sees 75% Upside TipRanks - 5/6/2021 5:01:38 AM
Zynerba receives FDA guidance for Phase 3 trial design for Zygel in rare genetic disorder Seeking Alpha - 5/5/2021 4:46:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2021 4:34:27 PM
Zynerba Pharmaceuticals Announces Phase 3 RECONNECT Trial Design for Zygel™ in Fragile X Syndrome GlobeNewswire Inc. - 5/5/2021 4:05:00 PM
Zynerba Pharmaceuticals Presents Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting GlobeNewswire Inc. - 4/29/2021 2:00:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/21/2021 9:02:25 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/21/2021 9:01:11 AM
Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting GlobeNewswire Inc. - 4/15/2021 7:30:00 AM
dhbuzz   Saturday, 10/05/19 12:09:06 AM
Re: Glider549 post# 1985
Post # of 2652 
WOW...LOL...Glad its not just me.You still in ?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences